The telomerase enzyme is a potential therapeutic target in many human cance
rs. A series of potent inhibitors has been designed by computer modeling, w
hich exploit the unique structural features of quadruplex DNA, These 3,6,9-
trisubstituted acridine inhibitors are predicted to interact selectively wi
th the human DNA quadruplex structure, as a means of specifically inhibitin
g the action of human telomerase in extending the length of single-stranded
telomeric: DNA. The anilino substituent at the 9-position of the acridine
chromophore is predicted to lie in a third groove of the quadruplex. Calcul
ated relative binding energies predict enhanced selectivity compared with e
arlier 3,6-disubstituted compounds, as a result of this substituent, The ra
nking order of energies is in accord with equilibrium binding constants for
quadruplex measured by surface plasmon resonance techniques, which also sh
ow reduced duplex binding compared with the disubstituted compounds. The 3,
6,9-trisubstututed acridines have potent in vitro inhibitory activity again
st human telomerase. with EC50 values of up to 60 nM.